Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3–Positive Acute Myeloid LeukemiaKristen M. Smith,Patrick C. Fagan,Elena Pomari,Giuseppe Germano,Chiara Frasson,Colin Walsh,Ian Silverman,Paolo Bonvini,Gang LiMolecular Cancer Therapeutics(2017)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要